[1]Íõº£Ñà,ÍõÓêÉú.ÖµµÃ¹Ø×¢µÄ·ÊºñÐÍÂöÂçĤ²¡±ä[J].ÑÛ¿ÆнøÕ¹,2020,40(3):201-205.[doi:10.13389/j.cnki.rao.2020.0048]
¡¡WANG Haiyan,WANG Yusheng.Pachychoroidopathy: a novel subject deserving of deep exploration[J].Recent Advances in Ophthalmology,2020,40(3):201-205.[doi:10.13389/j.cnki.rao.2020.0048]

µã»÷¸´ÖÆ

ÖµµÃ¹Ø×¢µÄ·ÊºñÐÍÂöÂçĤ²¡±ä/HTML

·ÖÏíµ½£º

²Î¿¼ÎÄÏ×/References:

£Û1£Ý¡¡FERRARA D,WAHEED N K,DUKER J S.Investigating the choriocapillaris and choroidal vasculature with new optical coherence tomography technologies£ÛJ£Ý.Prog Retin Eye Res,2016,52:130-155.
£Û2£Ý¡¡SINGH S R,VUPPARABOINA K K,GOUD A,DANSINGANI K K,CHHABLANI J.Choroidal imaging biomarkers£ÛJ£Ý.Surv Ophthalmol£¬2019,64(3):312-333.
£Û3£Ý¡¡BAEK J,LEE J H,JUNG B J,KOOK L,LEE W K.Morphologic features of large choroidal vessel layer:age-related macular degeneration,polypoidal choroidal vasculopathy,and central serous chorioretinopathy£ÛJ£Ý.Graefes Arch Clin Exp Ophthalmol,2018,256(12):2309-2317.
£Û4£Ý¡¡WARROW D J,HOANGQV,FREUND K B.Pachychoroid pigment epitheliopathy£ÛJ£Ý.Retina,2013,33(8):1659-1672.
£Û5£Ý¡¡CHEUNG C M G,LEE W K,KOIZUMI H,DANSINGANI K,LAI T Y Y,FREUND K B.Pachychoroid disease£ÛJ£Ý.Eye(Lond),2019,33(1):14-33.
£Û6£Ý¡¡AKKAYA S.Spectrum of pachychoroid diseases£ÛJ£Ý.Int Ophthalmol,2018,38(5):2239-2246.
£Û7£Ý¡¡GUPTA M P,RUSU I,SEIDMAN C,ORLIN A,D¡¯AMICO D J,KISS S.Pachychoroid neovasculopathy in extramacular choroidal neovascularization£ÛJ£Ý.Clin Ophthalmol,2016,10:1275-1282.
£Û8£Ý¡¡LEHMANN M,BOUSQUET E,BEYDOUN T,BEHAR-COHEN F.Pachychoroid:an inherited condition?£ÛJ£Ý.Retina,2015,35(1):10-16.
£Û9£Ý¡¡HIRATA M,TSUJIKAWA A,MATSUMOTO A,HANGAI M,OOTO S,YAMASHIRO K,et al.Macular choroidal thickness and volume in normal subjects measured by swept-source optical coherence tomography£ÛJ£Ý.Invest Ophthalmol Vis Sci,2011,52(8):4971-4978.
£Û10£Ý¡¡MARGOLIS R,SPAIDE R F.A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes£ÛJ£Ý.Am J Ophthalmol,2009,147(5):811-815.
£Û11£Ý¡¡CHAKRABORTY R,READ S A,COLLINS M J.Diurnal variations in axial length,choroidal thickness,intraocular pressure,and ocular biometrics£ÛJ£Ý.Invest Ophthalmol Vis Sci,2011,52(8):5121-5129.
£Û12£Ý¡¡DANSINGANI K K,BALARATNASINGAM C,NAYSAN J,FREUND K B.En face imaging of pachychoroid spectrum disorders with swept source optical coherence tomography£ÛJ£Ý.Retina,2016,36(3):499-516.
£Û13£Ý¡¡PHASUKKIJWATANA N,FREUND K B,DOLZ-MARCO R,AL-SHEIKH M,KEANE P A,EGAN C A,et al.Peripapillary pachychoroid syndrome£ÛJ£Ý.Retina,2018,38(9):1652-1667.
£Û14£Ý¡¡BAEK J,KOOK L,LEE W K.Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid£ÛJ£Ý.Sci Rep,2019,9(1):5565.
£Û15£Ý¡¡LEE W K,BAEK J,DANSINGANI K K,LEE J H,FREUND K B.Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness£ÛJ£Ý.Retina,2016,36(Suppl 1):S73-S82.
£Û16£Ý¡¡YANG L,JONAS J B,WEI W.Choroidal vessel diameter in central serous chorioretinopathy £ÛJ£Ý.Acta Ophthalmol,2013,91(5):e358-e362.
£Û17£Ý¡¡NAKAJIMA M,YUZAWA M,SHIMADA H,MORI R.Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy£ÛJ£Ý.Jpn J Ophthalmol,2004,48(3):249-255.
£Û18£Ý¡¡YUN C,HUH J,AHN S M,LEE B,KIM J T,HWANG S Y,et al.Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy£ÛJ£Ý.Graefes Arch Clin Exp Ophthalmol,2019,257(1):57-70.
£Û19£Ý¡¡GAL-OR O,DANSINGANI K K,SEBROW D,DOLZ-MARCO R,FREUND K B.Inner choroidal flow signal attenuation in pachychoroid disease:optical coherence tomography angiography£ÛJ£Ý.Retina,2018,38(10):1984-1992.
£Û20£Ý¡¡LEE M,LEE H,KIM H C,CHUNG H.Changes in stromal and luminal areas of the choroid in pachychoroid diseases:insights into the pathophysiology of pachychoroid diseases£ÛJ£Ý.Invest Ophthalmol Vis Sci,2018,59(12):4896-4908.
£Û21£Ý¡¡PANG C E,FREUND K B.Pachychoroid neovasculopathy£ÛJ£Ý.Retina,2015,35(1):1-9.
£Û22£Ý¡¡DANSINGANI K K,BALARATNASINGAM C,KLUFAS M A,SARRAF D,FREUND K B.Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease£ÛJ£Ý.Am J Ophthalmol,2015,160(6):1243-1254.
£Û23£Ý¡¡BALARATNASINGAM C,LEE W K,KOIZUMI H,DANSINGANI K,INOUE M,FREUND K B.Polypoidal choroidal vasculopathy:a distinct disease or manifestation of many? £ÛJ£Ý.Retina,2016,36(1):1-8.
£Û24£Ý¡¡SPAIDE R F.Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness£ÛJ£Ý.Retina,2018,38(4):708-716.
£Û25£Ý¡¡BAEK J,LEE J H,CHUNG B J,LEE K,LEE W K.Choroidal morphology under pachydrusen £ÛJ£Ý.Clin Exp Ophthalmol,2019,47(4):498-504.
£Û26£Ý¡¡MATSUMOTO H,MUKAI R,MORIMOTO M,TOKUI S,KISHI S,AKIYAMA H.Clinical characteristics of pachydrusen in central serous chorioretinopathy£ÛJ£Ý.Graefes Arch Clin Exp Ophthalmol,2019,257(6):1127-1132.
£Û27£Ý¡¡BAE K,NAM S W,KANG S W,KIM E S,YU S Y,KIM K T,et al.Central serous chorioretinopathy in elderly subjects:angiographic and tomographic characteristics£ÛJ£Ý.Graefes Arch Clin Exp Ophthalmol,2019,257(2):279-288.
£Û28£Ý¡¡LEE J,CHOI S,LEE C S,KIM M,KIM S S,KOH H J,et al.Neovascularization in fellow eye of unilateral neovascular age-related macular degeneration according to different drusen types£ÛJ£Ý.Am J Ophthalmol,2019,208:103-110.
£Û29£Ý¡¡LEE J,KIM M,LEE C S,KIM S S,KOH H J,LEE S C,et al.Drusen subtypes and choroidal characteristics in asian eyes with typical neovascular age-related macular degeneration£ÛJ£Ý.Retina,2020,40(3):490-498.
£Û30£Ý¡¡TAKAHASHI A,OOTO S,YAMASHIRO K,TAMURA H,OISHI A,MIYATA M,et al.Pachychoroid geographic atrophy:clinical and genetic characteristics£ÛJ£Ý.Ophthalmol Retina,2018,2(4):295-305.
£Û31£Ý¡¡NAGIA L,HUISINGH C,JOHNSTONE J,KLINE L B,CLARK M,GIRARD M J,et al.Peripapillary pachychoroid in nonarteritic anterior ischemic optic neuropathy£ÛJ£Ý.Invest Ophthalmol Vis Sci,2016,57(11):4679-4685.
£Û32£Ý¡¡SONODA S,SAKAMOTO T,KUROIWA N,ARIMURA N,KAWANO H,YOSHIHARA N,et al.Structural changes of inner and outer choroid in central serous chorioretinopathy determined by optical coherence tomography£ÛJ£Ý.PLoS One,2016,11(6):e0157190.
£Û33£Ý¡¡LAI K,ZHOU L,ZHONG X,HUANG C,GONG Y,XU F,et al.Morphological difference of choroidal vasculature between polypoidal choroidal vasculopathy and neovascular AMD on oct:from the perspective of pachychoroid£ÛJ£Ý.Ophthalmic Surg Lasers Imaging Retina,2018,49(10):e114-e121.
£Û34£Ý¡¡DAIZUMOTO E,MITAMURA Y,SANO H,AKAIWA K,NIKI M,YAMANAKA C,et al.Changes of choroidal structure after intravitreal aflibercept therapy for polypoidal choroidal vasculopathy£ÛJ£Ý.Br J Ophthalmol,2017,101(1):56-61.
£Û35£Ý¡¡SHETH J,ANANTHARAMAN G,CHANDRA S,SIVAPRASAD S.¡°Double-layer sign¡± on spectral domain optical coherence tomography in pachychoroid spectrum disease£ÛJ£Ý.Indian J Ophthalmol,2018,66(12):1796-1801.
£Û36£Ý¡¡LEE J H,KIM J Y,JUNG B J,LEE W K.Focal disruptions in ellipsoid zone and interdigitation zone on spectral-domain optical coherence tomography in pachychoroid pigment epitheliopathy£ÛJ£Ý.Retina,2019,39(8):1562-1570.
£Û37£Ý¡¡ERSOZ M G,KARACORLU M,ARF S,HOCAOGLU M,SAYMAN MUSLUBAS I.Outer nuclear layer thinning in pachychoroid pigment epitheliopathy£ÛJ£Ý.Retina,2018,38(5):957-961.
£Û38£Ý¡¡KANG H,BYEON S H,KIM S S,KOH H J,LEE S C,KIM M.Combining enface optical coherence tomography angiography with structural optical coherence tomography and blood flow analysis for detecting choroidal neovascular complexes in pigment epithelial detachments£ÛJ£Ý.Retina,2019,39(8):1551-1561.
£Û39£Ý¡¡CARNEVALI A,CAPUANO V,SACCONI R,QUERQUES L,MARCHESE A,RABIOLO A,et al.OCT angiography of treatment-na¢†ve quiescent choroidal neovascularization in pachychoroid neovasculopathy£ÛJ£Ý.Ophthalmol Retin,2017,1(4):328-332.
£Û40£Ý¡¡DEMIREL S,YANIK ¦Z,NALCI H,BATIO G LU F,¦ZZMERT E.The use of optical coherence tomography angiography in pachychoroid spectrum diseases:a concurrent comparison with dye angiography£ÛJ£Ý.Graefes Arch Clin Exp Ophthalmol,2017,255(12):2317-2324.
£Û41£Ý¡¡CHEUNG C M G,LAI T Y Y,RUAMVIBOONSUK P,CHEN S J,CHEN Y,FREUND K B,et al.Polypoidal choroidal vasculopathy:definition,pathogenesis,diagnosis,and management£ÛJ£Ý.Ophthalmology,2018,125(5):708-724.
£Û42£Ý¡¡ERSOZ M G,ARF S,HOCAOGLU M,SAYMAN MUSLUBAS I,KARACORLU M.Indocyanine green angiography of pachychoroid pigment epitheliopathy£ÛJ£Ý.Retina,2018,38(9):1668-1674.
£Û43£Ý¡¡SAKURADA Y,FRAGIOTTA S,LEONG B C S,PARIKH R,HUSSNAIN S A,FREUND K B.Relationship between choroidal vascular hyperpermeability,choriocapillaris flow density,and choroidal thickness in eyes with pachychoroid pigment epitheliopathy£ÛJ£Ý.Retina,2019,£ÛEpub ahead of print£Ý.
£Û44£Ý¡¡ERSOZ M G,KARACORLU M,ARF S,HOCAOGLU M,SAYMAN MUSLUBAS I.Pachychoroid pigment epitheliopathy in fellow eyes of patients with unilateral central serous chorioretinopathy£ÛJ£Ý.Br J Ophthalmol,2018,102(4):473-478.
£Û45£Ý¡¡KARACORLU M,ERSOZ M G,ARF S,HOCAOGLU M,SAYMAN MUSLUBAS I.Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics£ÛJ£Ý.Graefes Arch Clin Exp Ophthalmol,2018,256(12):2319-2326.
£Û46£Ý¡¡TOYAMA T,OHTOMO K,NODA Y,UETA T.Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy£ÛJ£Ý.Eye(Lond),2014,28(8):992-997.
£Û47£Ý¡¡MANAYATH G J,SHAH V S,SARAVANAN V R,NARENDRAN V.Polypoidal choroidal vasculopathy associated with central serous chorioretinopathy:pachychoroid spectrum of diseases£ÛJ£Ý.Retina,2018,38(6):1195-1204.
£Û48£Ý¡¡SPAIDE R F.Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization£ÛJ£Ý.Am J Ophthalmol,2015,160(1):6-16.
£Û49£Ý¡¡TERAO N,KOIZUMI H,KOJIMA K,YAMAGISHI T,YAMAMOTO Y,YOSHII K,et al.Distinct aqueous humour cytokine profiles of patients with pachychoroid neovasculopathy and neovascular age-related macular degeneration £ÛJ£Ý.Sci Rep,2018,8(1):10520.
£Û50£Ý¡¡HATA M,YAMASHIRO K,OOTO S,OISHI A,TAMURA H,MIYATA M,et al.Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration£ÛJ£Ý.Invest Ophthalmol Vis Sci,2017,58(1):292-298.
£Û51£Ý¡¡AZUMA K,TAN X,ASANO S,SHIMIZU K,OGAWA A,INOUE T,et al.The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy£ÛJ£Ý.PLoS One,2019,14(2):e0212055.
£Û52£Ý¡¡MATSUMOTO H,HIROE T,MORIMOTO M,MIMURA K,ITO A,AKIYAMA H.Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration£ÛJ£Ý.Jpn J Ophthalmol,2018,62(2):144-150.
£Û53£Ý¡¡JUNG B J,KIM J Y,LEE J H,BAEK J,LEE K,LEE W K.Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy£ÛJ£Ý.Sci Rep,2019,9(1):2055.
£Û54£Ý¡¡KOIZUMI H,YAMAGISHI T,YAMAZAKI T,KINOSHITA S.Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability £ÛJ£Ý.Am J Ophthalmol,2013,155(2):305-313.
£Û55£Ý¡¡KIM H,LEE S C,KWON K Y,LEE J H,KOH H J,BYEON S H,et al.Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy£ÛJ£Ý.Graefes Arch Clin Exp Ophthalmol,2016,254(8):1497-1503.
£Û56£Ý¡¡CHANG Y C,CHENG C K.Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy£ÛJ£Ý.Retina,2019, £ÛEpub ahead of print£Ý.
£Û57£Ý¡¡NAGAI N,SUZUKI M,MINAMI S,KURIHARA T,KAMOSHITA M,SONOBE H,et al.Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy£ÛJ£Ý.Sci Rep,2019,9(1):11389.
£Û58£Ý¡¡BAEK J,LEE J H,JEON S,LEE W K.Choroidal morphology and short-term outcomes of combination photodynamic therapy in polypoidal choroidal vasculopathy£ÛJ£Ý.Eye(Lond),2019 33(3):419-427.
£Û59£Ý¡¡HOSODA Y,YOSHIKAWA M,MIYAKE M,TABARA Y,AHN J,WOO S J,et al.CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy£ÛJ£Ý.Proc Natl Acad Sci U S A,2018,115(24):6261-6266.
£Û60£Ý¡¡MIYAKE M,OOTO S,YAMASHIRO K,TAKAHASHI A,YOSHIKAWA M,AKAGI-KURASHIGE Y,et al.Pachychoroid neovasculopathy and age-related macular degeneration£ÛJ£Ý.Sci Rep,2015,5:16204.